CSF3 and acute graft versus host disease: In the univariate analysis, the cumulative incidence of grades II–IV acute GVHD significantly varied with the administration and timing of G‐CSF initiation following BMT (p = .005) and CBT (p = .005), but not PBSCT (p = .158) (Figure 3A–C).